Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Peer review reports

Original Submission
4 Jun 2019	Submitted	Original manuscript
11 Jul 2019	Reviewed	Reviewer Report - Diederik de Cock
22 Jul 2019	Reviewed	Reviewer Report - Katie Druce
31 Oct 2019	Author responded	Author comments - Philip Brenner
Resubmission - Version 2
31 Oct 2019	Submitted	Manuscript version 2
Publishing
18 Nov 2019	Editorially accepted
12 Feb 2020	Article published	10.1186/s41927-019-0106-3

Back to article page